Artificial Intelligence

AstraZeneca and CSPC Enter $5.3B AI-Driven Drug Discovery Pact in China

2 weeks ago talkbio0Tagged Aortic Valve Insufficiency, Artificial Intelligence, AstraZeneca, China, Chronic disease, Dosage Forms, Drug Discovery, GZMH gene, Investments, oral therapies, Partnership, R&D, research

AstraZeneca; CSPC Pharmaceutical; AI research; drug discovery; chronic diseases; China; $5.3 billion; oral therapies; partnership; R&D investment

AstraZeneca Signs $110M AI-Driven R&D Deal with CSPC Pharmaceutical for Chronic Disease Drugs

3 weeks ago talkbio0Tagged Aortic Valve Insufficiency, Artificial Intelligence, AstraZeneca, China pharma, Chronic disease, Collaboration, Dosage Forms, Drug Discovery, Drug Industry, GZMH gene, Immune System Diseases, milestone payments, oral therapies

AstraZeneca; CSPC Pharmaceutical; AI drug discovery; chronic diseases; immunological diseases; oral therapies; R&D collaboration; China pharma; milestone payments; pharmaceutical industry

NVIDIA and Novo Nordisk Partner to Accelerate AI-Driven Drug Discovery

3 weeks ago talkbio0Tagged AI models, Artificial Intelligence, BioNeMo, Drug Discovery, Gefion AI Supercomputer, Nordisk, NVIDIA, Omniverse, pharmaceutical innovation

NVIDIA; Novo Nordisk; AI models; drug discovery; Gefion AI Supercomputer; BioNeMo; Omniverse; pharmaceutical innovation

Inside ASCO 2025: Big Data Drops and a Towering Campaign – Key News Highlights

3 weeks ago talkbio0Tagged 2025, Artificial Intelligence, ASCO, Big Data, campaigns, Cancer Research, Clinical Oncology, erbB-2 Receptor, Malignant neoplasm of breast, Malignant neoplasm of lung

ASCO 2025; cancer research; big data; campaigns; clinical oncology; artificial intelligence; HER2; lung cancer; breast cancer; therapeutic vaccines

MIT’s Boltz-1 AI Model Rivals AlphaFold 3 in Biomolecular Structure Prediction

4 weeks ago talkbio0Tagged AlphaFold, Aortic Valve Insufficiency, Artificial Intelligence, biomolecular structure prediction, Boltz-1, Drug Discovery, MIT, open-source AI, protein folding

MIT; Boltz-1; AlphaFold 3; AI model; biomolecular structure prediction; drug discovery; protein folding; open-source AI

Recent Developments in Building Robust Health System Partnerships for Life Sciences (2025)

1 month ago talkbio0Tagged Artificial Intelligence, Biological Science Disciplines, Biotechnology, Computer Security, Data Integration, digital transformation, health system partnerships, Primary Health Care, Salesforce Life Sciences Cloud, strategic partnerships

health system partnerships; life sciences; strategic partnerships; digital transformation; artificial intelligence; cybersecurity; primary care; biotechnology; Salesforce Life Sciences Cloud; data integration

FDA eyes full AI integration by June as Makary touts genAI pilot success

2 months ago talkbio0Tagged Aortic Valve Insufficiency, Artificial Intelligence, DNA Integration, June, Makary, United States Food and Drug Administration

United States Food and Drug Administration, Aortic Valve Insufficiency, DNA Integration, Artificial Intelligence, Makary, June

AI Drug Discovery Firm Insitro Lays Off 22% of Workforce Amid Ongoing Biotech Market Turmoil

2 months ago talkbio0Tagged Ambulatory Care Facilities, Aortic Valve Insufficiency, Artificial Intelligence, Biotech Layoffs, biotechnology layoffs, Drug Discovery, Industry, Insitro, Market, Readiness, restructuring, trends qualifier

Insitro, AI drug discovery, biotechnology layoffs, workforce reduction, tumultuous market, industry restructuring, biotech market trends, clinic readiness, cost-cutting, 2025 biotech layoffs

Deerfield raises $600M healthcare fund to invest in therapeutics, AI

2 months ago talkbio0Tagged Artificial Intelligence, Deerfield, Drug Development, Health care facility, Investments

Deerfield, Artificial Intelligence, Investments, Drug Development, Health care facility

FDA chief Makary talks expediting drug approvals, RIFs and the abortion pill

2 months ago talkbio0Tagged Accelerated, Agencies, Artificial Intelligence, Califf, Contraceptives, Oral, Infrequent, RIFs, United States Food and Drug Administration, Unspecified Abortion

United States Food and Drug Administration, Califf, Unspecified Abortion, Contraceptives, Oral, Accelerated, Artificial Intelligence, RIFs, Infrequent, Agencies